US Stock MarketDetailed Quotes

GPCR Structure Therapeutics

Watchlist
  • 34.010
  • +0.600+1.80%
Close Nov 25 16:00 ET
  • 33.520
  • -0.490-1.44%
Post 17:44 ET
1.95BMarket Cap-17612P/E (TTM)

Structure Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Structure Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Structure Therapeutics Earnings Reports

  • Structure Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 22:32 ET

  • Structure Therapeutics | 8-K: Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights First patients dosed in Phase 2b ACCESS study of GSBR-1290 for obesity

    Nov 13 16:17 ET

  • Structure Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:40 ET

  • Structure Therapeutics | 8-K: Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights

    Aug 8 16:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 9, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme Weight Loss Drugs
    Weight Loss Drugs
    Intraday+0.47%
    Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday+0.38%